Physician profile
Mark A Channer
NPI 1649259441
$7,793.84
in general payments reported to CMS, 2019-2025
6 companies · $108 in 2025
The $108 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $295 · 2020: $43.92 · 2021: $72.25 · 2022: $5,447 · 2023: $446 · 2024: $1,382 · 2025: $108.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,130 · Food and Beverage: $806.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,130.19 |
| Food and Beverage | $805.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medacta USA, INC. | $7,086.01 | 2022-2025 | Mpact, Gmk Sphere |
| Stryker Corporation | $342.53 | 2019-2023 | Triathlon |
| Zimmer Biomet Holdings, INC. | $165.39 | 2019-2023 | Persona |
| Orthalign INC | $94.25 | 2023 | Orthalign Plus |
| Pacira Pharmaceuticals Incorporated | $84.33 | 2023 | Iovera |
| Heron Therapeutics, INC. | $21.33 | 2025 | Zynrelef |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Channer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.